# A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

> **NCT02730689** · PHASE1 · COMPLETED · sponsor: **Alvogen Korea** · enrollment: 66 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** DP-R207
- **DRUG:** Rosuvastatin
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT02730689
- **Lead sponsor:** Alvogen Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730689, "A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02730689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*